Furthermore, we identified Wnt response elements in the breast cancer relevant aromatase promoter I.3/II region, and identified a switch in promoter occupancy from TCF-4 to a LEF-1 variant, which appears to be involved in the WNT3a induced suppression of aromatase in BAFs. Here, CYP19A1 is linked to breast carcinoma.